Clinical Trial Detail

NCT ID NCT03992131
Title A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

ovarian cancer

Advanced Solid Tumor

transitional cell carcinoma

triple-receptor negative breast cancer

Therapies

Lucitanib + Rucaparib

Rucaparib + Sacituzumab govitecan-hziy

Age Groups: adult senior

No variant requirements are available.